We recently compiled a list of the 10 Best Alcohol Stocks To Buy According to Analysts. In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against the other ...

In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against the other alcohol stocks. An analysis by Goldman Sachs has revealed that beer and spirits ...

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

There could be progress on the cannabis legalization front in the next five years. Whether Tilray benefits from this will depend on a lot of factors. The company's outlook remains risky and uncertain.

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

One of the top cannabis stocks in the industry is Tilray Brands (TLRY-1.11%), and during that stretch, its valuation has crumbled, falling by a staggering 94%. The Canada-based company has been ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...